title: Commentary: once-daily aminoglycoside dosing: where are we now?
authors.affiliation: Evidence-Based Prescribing Initiative, London Health Sciences Centre, London, Ontario, Canada. janet.martin@lhsc.on.ca
authors.forename: Janet E
authors.initials: JE
authors.lastname: Martin
mesh_terms: D000583:Amikacin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D000617:Aminoglycosides / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D003428:Cross Infection / Q000188:drug therapy / Q000378:metabolism; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007362:Intensive Care Units
chemical_list: D000617:Aminoglycosides; D000583:Amikacin